biztrac. BETA
COMPANY REGISTER PROFILE
995549484 ORG. NO. 2025 ACCOUNTS 7 SECTIONS
Active UPDATED 03.10.2026
Retail sale of pharmaceutical products

SOLBERGELVA APOTEK AS

Org. no. 995549484 Limited company (AS) Drammen Incorporated 2010 Active
Revenue 2025 NOK 20.0m
Operating profit NOK 1.1m
Equity NOK 2.2m
Incorporated 2010
Share capital NOK 100,000

SOLBERGELVA APOTEK AS is registered as a limited company in Drammen, Buskerud with organisation number 995549484. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2010. Registered share capital is NOK 100,000, divided into 1000 shares. The company's stated purpose is: “Drive med butikkhandel med apotekvarer.”. The most recent filed accounts, for the 2025 financial year, show NOK 20.0m in revenue and NOK 1.1m in operating profit.

Key figures · 2025

Revenue
NOK 20.0m
▲ +5 %
Operating profit
NOK 1.1m
▼ −10 %
Equity
NOK 2.2m
▲ +35 %
Est. value
NOK 5.4m

Financial health · 2025

Liquidity
1.67
Good
Current assets ÷ current liabilities
Profitability
23.1%
Very good
Return on total assets
Solidity
41.7%
Very good
Equity as a share of total capital

Who owns SOLBERGELVA APOTEK AS?

SOLBERGELVA APOTEK AS
NOK 20.0m rev. · NOK 1.1m profit

SOLBERGELVA APOTEK AS has 2 registered shareholders:

All shareholders and roles →

Frequently asked questions about SOLBERGELVA APOTEK AS

Who owns SOLBERGELVA APOTEK AS?

Chuong Hoang Vo is the largest registered owner, with 50.0%.

What is the revenue of SOLBERGELVA APOTEK AS?

SOLBERGELVA APOTEK AS had revenue of NOK 20.0m in 2025.

Who is the general manager of SOLBERGELVA APOTEK AS?

Dao Bich Thi Tran is registered as general manager of SOLBERGELVA APOTEK AS.

Where is SOLBERGELVA APOTEK AS based?

SOLBERGELVA APOTEK AS has its business address in Solbergelva.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.